Structures by: Bolla G.
Total: 125
CEL2HP
C17H14F3N3O2S,C5H5NO
IUCrJ (2019) 6, 4
a=14.5182(15)Å b=8.2844(12)Å c=17.8349(18)Å
α=90° β=93.899(9)° γ=90°
CELMeHP
C17H14F3N3O2S,C6H7NO
IUCrJ (2019) 6, 4
a=10.0694(8)Å b=10.6113(10)Å c=12.6499(14)Å
α=113.451(10)° β=100.897(8)° γ=101.744(7)°
CELMeTFHP
C17H14F3N3O2S,C7H6F3NO
IUCrJ (2019) 6, 4
a=7.4563(9)Å b=13.0100(15)Å c=13.7231(16)Å
α=100.170(2)° β=95.715(2)° γ=104.444(2)°
CELOMeHP
C6H7NO2,C17H14F3N3O2S
IUCrJ (2019) 6, 4
a=7.6112(9)Å b=11.3462(14)Å c=15.1063(18)Å
α=105.897(2)° β=102.702(2)° γ=101.930(2)°
FUROS2PY
2(C12H11ClN2O5S),C2H7O,2(C4H7NO)
IUCrJ (2019) 6, 4
a=23.819(3)Å b=8.4372(5)Å c=23.450(2)Å
α=90° β=123.868(16)° γ=90°
FUROSCPR
C12H11ClN2O5S,C6H11NO
IUCrJ (2019) 6, 4
a=8.5442(6)Å b=11.3615(8)Å c=12.1409(8)Å
α=63.4470(10)° β=88.7240(10)° γ=75.7120(10)°
FUROSVLM
C12H11ClN2O5S,C5H9NO,H2O
IUCrJ (2019) 6, 4
a=11.116(5)Å b=8.447(2)Å c=21.388(7)Å
α=90° β=93.12(3)° γ=90°
HCT2HPFORMI
C7H8ClN3O4S2,C5H5NO
IUCrJ (2019) 6, 4
a=6.8039(5)Å b=13.5399(8)Å c=18.8949(13)Å
α=90° β=113.113(9)° γ=90°
HCTHPFORMII
C7H8ClN3O4S2,C5H5NO
IUCrJ (2019) 6, 4
a=29.442(4)Å b=7.3421(9)Å c=7.0867(7)Å
α=90° β=90° γ=90°
HCTVLM12
C7H8ClN3O4S2,2(C5H9NO)
IUCrJ (2019) 6, 4
a=8.6930(6)Å b=10.6472(7)Å c=12.8556(9)Å
α=113.6720(10)° β=98.9000(10)° γ=95.3580(10)°
HCTCPR12
C7H8ClN3O4S2,2(C6H11NO)
IUCrJ (2019) 6, 4
a=11.8873(12)Å b=19.315(2)Å c=21.733(2)Å
α=90° β=90° γ=90°
ACEMETACIN2PYRIDONE
C21H18ClNO6,C5H5NO
IUCrJ (2017) 4, 3
a=23.1400(18)Å b=5.1900(8)Å c=21.2642(19)Å
α=90.00° β=111.714(17)° γ=90.00°
ACEMETACINNICOTINAMIDEFORMII
C21H18ClNO6,C6H6N2O,H2O
IUCrJ (2017) 4, 3
a=21.348(2)Å b=4.1931(12)Å c=15.2174(19)Å
α=90.567(17)° β=101.40(2)° γ=89.473(16)°
ACEMETACINNICOTINAMIDEFORMI
C21H18ClNO6,C6H6N2O
IUCrJ (2017) 4, 3
a=4.8977(11)Å b=40.914(4)Å c=12.8874(19)Å
α=90.00° β=100.328(18)° γ=90.00°
ACEMETACINPABA
C21H18ClNO6,C7H7NO2
IUCrJ (2017) 4, 3
a=17.2939(18)Å b=4.8191(7)Å c=16.9544(15)Å
α=90.00° β=113.529(17)° γ=90.00°
ACEMETACINVLM
C21H18ClNO6,C5H9NO
IUCrJ (2017) 4, 3
a=11.7638(12)Å b=20.5548(19)Å c=5.1627(9)Å
α=89.543(14)° β=93.300(16)° γ=96.276(17)°
C21H18ClNO6,C6H6N2O
C21H18ClNO6,C6H6N2O
IUCrJ (2014) 1, 2 136-150
a=21.7202(15)Å b=5.0077(14)Å c=11.8457(17)Å
α=90.00° β=93.954(13)° γ=90.00°
ACM-INA
C21H18ClNO6,C6H6N2O
IUCrJ (2014) 1, 2 136-150
a=11.8900(8)Å b=4.9621(3)Å c=21.4281(14)Å
α=90.00° β=90.663(6)° γ=90.00°
ACM-CPR
C21H18ClNO6,C6H11NO
IUCrJ (2014) 1, 2 136-150
a=11.9406(16)Å b=21.3081(19)Å c=5.1030(14)Å
α=92.373(15)° β=93.003(16)° γ=85.308(17)°
C6H8N2O2S,C6H11NO
C6H8N2O2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.2731(4)Å b=15.9052(10)Å c=12.7766(6)Å
α=90.00° β=99.291(5)° γ=90.00°
C6H7NO2S,C7H13NO
C6H7NO2S,C7H13NO
IUCrJ (2015) 2, 4 389-401
a=7.3020(9)Å b=17.189(2)Å c=12.2835(16)Å
α=90.00° β=106.760(2)° γ=90.00°
C6H6ClNO2S,C6H11NO
C6H6ClNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.1564(13)Å b=13.369(2)Å c=15.276(3)Å
α=90.00° β=90.00° γ=90.00°
C6H8N2O2S,C6H11NO
C6H8N2O2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.0957(6)Å b=13.1280(13)Å c=15.3425(18)Å
α=90.00° β=90.00° γ=90.00°
C6H6BrNO2S,C6H11NO
C6H6BrNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.156(3)Å b=13.538(5)Å c=15.406(6)Å
α=90.00° β=90.00° γ=90.00°
C6H6ClNO2S,C6H11NO
C6H6ClNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=9.8782(6)Å b=14.1720(6)Å c=10.8753(6)Å
α=90.00° β=112.850(7)° γ=90.00°
C7H9NO2S,C5H9NO
C7H9NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=5.3367(6)Å b=15.9206(17)Å c=16.070(3)Å
α=90.00° β=98.308(12)° γ=90.00°
C6H7NO2S,C6H11NO
C6H7NO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.0700(9)Å b=12.7624(13)Å c=14.977(2)Å
α=90.00° β=90.00° γ=90.00°
C6H6ClNO2S,C5H9NO
C6H6ClNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=25.701(4)Å b=6.8096(4)Å c=19.177(3)Å
α=90.00° β=127.40(2)° γ=90.00°
C6H6BrNO2S,C5H9NO
C6H6BrNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=25.914(3)Å b=6.8687(9)Å c=19.202(2)Å
α=90.00° β=126.873(2)° γ=90.00°
C7H9NO2S,C5H9NO
C7H9NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=5.210(3)Å b=8.449(4)Å c=16.104(8)Å
α=82.894(8)° β=82.798(8)° γ=81.772(8)°
C6H6ClNO2S,C5H9NO
C6H6ClNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=10.521(2)Å b=13.7661(12)Å c=10.3407(16)Å
α=90.00° β=116.31(2)° γ=90.00°
C6H7NO2S,C5H9NO
C6H7NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=7.1043(5)Å b=12.7937(10)Å c=14.0302(16)Å
α=90.00° β=90.00° γ=90.00°
ACETAZOLAMIDE;DMSO
C4H6N4O3S2,0.5(C2H6OS)
IUCrJ (2016) 3, 2 152-160
a=52.62(3)Å b=4.816(2)Å c=17.814(9)Å
α=90.00° β=106.785(13)° γ=90.00°
ACETAZOLAMIDE;2 PYRIDONE
C4H6N4O3S2,C5H5NO
IUCrJ (2016) 3, 2 152-160
a=4.9138(4)Å b=33.192(3)Å c=8.3659(7)Å
α=90.00° β=99.5200(10)° γ=90.00°
ACETAZOLAMIDE;2 PYRIDONE
C4H6N4O3S2,2(C5H5NO)
IUCrJ (2016) 3, 2 152-160
a=6.8501(3)Å b=11.3563(6)Å c=12.3387(8)Å
α=82.288(5)° β=81.856(4)° γ=75.804(4)°
ACETAZOLAMIDE; CAPROLACTAM; HYDRATE
C4H6N4O3S2,C6H11NO,H2O
IUCrJ (2016) 3, 2 152-160
a=4.9969(2)Å b=11.6983(6)Å c=14.6244(8)Å
α=70.868(5)° β=81.892(4)° γ=80.262(4)°
ACETAZOLAMIDE;NICOTINAMIDE
C4H6N4O3S2,C6H6N2O
IUCrJ (2016) 3, 2 152-160
a=5.1477(8)Å b=10.8147(14)Å c=14.2604(16)Å
α=69.797(11)° β=85.463(12)° γ=81.889(12)°
ACETAZOLAMIDE;6 Me 2 PYRIDONE
C4H6N4O3S2,C6H7NO
IUCrJ (2016) 3, 2 152-160
a=11.3972(7)Å b=18.1641(3)Å c=10.338(3)Å
α=90.00° β=97.046(16)° γ=90.00°
ACETAZOLAMIDE; 3 OME 2 PYRIDONE
C4H6N4O3S2,C6H7NO2,H2O
IUCrJ (2016) 3, 2 152-160
a=7.7872(6)Å b=10.2130(7)Å c=10.2464(7)Å
α=88.192(5)° β=76.587(6)° γ=77.996(6)°
ACETAZOLAMIDE;NICOTINAMIDE; 2 PYRIDONE
C4H6N4O3S2,C6H6N2O,C5H5NO
IUCrJ (2016) 3, 2 152-160
a=7.0347(3)Å b=10.2539(7)Å c=13.7934(9)Å
α=81.685(6)° β=83.028(5)° γ=88.283(5)°
ACETAZOLAMIDE; VALEROLACTAM
C4H6N4O3S2,2(C5H9NO)
IUCrJ (2016) 3, 2 152-160
a=9.66166(19)Å b=23.4685(4)Å c=8.84352(17)Å
α=90.00° β=100.7730(19)° γ=90.00°
ABZ BSAH
C12H16N3O2S,C6H5O3S,H2O
CrystEngComm (2018) 20, 41 6394
a=8.9020(6)Å b=9.2715(8)Å c=14.2635(12)Å
α=84.984(7)° β=89.142(6)° γ=63.976(7)°
ABZ-PTSAH
C12H16N3O2S,C7H7O3S,H2O
CrystEngComm (2018) 20, 41 6394
a=8.900(5)Å b=9.573(5)Å c=14.453(8)Å
α=83.026(9)° β=72.434(8)° γ=63.151(8)°
C19H23N3O5S2
C19H23N3O5S2
CrystEngComm (2018) 20, 41 6394
a=15.2992(17)Å b=9.7420(9)Å c=15.8825(14)Å
α=90° β=115.573(12)° γ=90°
ABZ-BSA
C12H16N3O2S,C6H5O3S
CrystEngComm (2018) 20, 41 6394
a=8.5042(7)Å b=9.4678(7)Å c=26.084(2)Å
α=96.005(6)° β=93.966(7)° γ=102.377(7)°
ABZ-OAH
C12H12N3O2S,C2HO4,H2O
CrystEngComm (2018) 20, 41 6394
a=5.2659(7)Å b=28.337(4)Å c=11.2029(15)Å
α=90° β=93.925(2)° γ=90°
ABZ-26DHBA
C12H8N3O2S,C12H8N3O2S,2(C7H5O4)
CrystEngComm (2018) 20, 41 6394
a=17.176(5)Å b=9.293(3)Å c=25.789(8)Å
α=90° β=105.950(5)° γ=90°
Indapamide-4,4'-Bipyridine cocrystal
C16H16ClN3O3S,C10H8N2
CrystEngComm (2019) 21, 13 2043
a=7.2851(14)Å b=9.0281(17)Å c=38.510(7)Å
α=90° β=95.230(3)° γ=90°
Indapamide-methylpyridone cocrystal
C16H16ClN3O3S,C6H7NO
CrystEngComm (2019) 21, 13 2043
a=7.765(7)Å b=8.741(8)Å c=34.52(3)Å
α=90° β=93.96(4)° γ=90°
Indapamide-2,2'-Bipyridine cocrystal
C16H16ClN3O3S,C10H8N2
CrystEngComm (2019) 21, 13 2043
a=7.3151(2)Å b=8.9370(3)Å c=38.9526(12)Å
α=90° β=93.702(2)° γ=90°
Indapamide-Phenazine cocrystal
C16H16ClN3O3S,C12H8N2
CrystEngComm (2019) 21, 13 2043
a=7.1759(3)Å b=9.4074(4)Å c=39.0523(17)Å
α=90° β=93.389(2)° γ=90°
Indapamide-1,2-Bis(4-pyridyl)ethylene cocrystal monohydrate
C16H16ClN3O3S,C12H10N2,H2O
CrystEngComm (2019) 21, 13 2043
a=12.2238(2)Å b=14.8267(3)Å c=16.2328(3)Å
α=93.2280(10)° β=107.2640(10)° γ=90.1220(10)°
Acetaminophen
C8H9NO2
CrystEngComm (2018) 20, 15 2084
a=11.7678(7)Å b=7.1966(5)Å c=17.1615(11)Å
α=90° β=90° γ=90°
Sulfonamide benzoic acid; 2pyridone form I
C7H7NO4S,C5H5NO
Chem.Commun. (2015) 51, 15578
a=14.990(4)Å b=11.3156(3)Å c=7.90(2)Å
α=90.00° β=95.96(11)° γ=90.00°
Sulfonamide benzoic acid; 2pyridone form III
C7H7NO4S,C5H5NO
Chem.Commun. (2015) 51, 15578
a=8.464(3)Å b=9.721(3)Å c=16.137(5)Å
α=90.00° β=100.001(5)° γ=90.00°
Sulfonamide benzoic acid; isonicotinamide
C7H7NO4S,C6H6N2O
Chem.Commun. (2015) 51, 15578
a=31.237(4)Å b=5.1056(6)Å c=20.362(2)Å
α=90.00° β=124.550(2)° γ=90.00°
Sulfonamide benzoic acid; 6methyl 2pyridone
C7H7NO4S,2(C6H7NO)
Chem.Commun. (2015) 51, 15578
a=7.3848(8)Å b=31.150(3)Å c=8.9746(9)Å
α=90.00° β=90.676(2)° γ=90.00°
Sulfonamide benzoic acid; nicotinamide; 2pyridone
C7H7NO4S,C6H6N2O,C5H5NO
Chem.Commun. (2015) 51, 15578
a=19.7594(7)Å b=5.25798(10)Å c=20.2747(7)Å
α=90.00° β=117.924(4)° γ=90.00°
Sulfonamide benzoic acid; nicotinamide; 6methyl 2pyridone
C7H7NO4S,C6H6N2O,C6H7NO
Chem.Commun. (2015) 51, 15578
a=8.2357(8)Å b=26.102(3)Å c=9.2781(9)Å
α=90.00° β=98.283(2)° γ=90.00°
Sulfonamide benzoic acid; caprolactam
C7H7NO4S,2(C6H11NO)
Chem.Commun. (2015) 51, 15578
a=7.0964(5)Å b=16.230(2)Å c=19.1256(15)Å
α=90.00° β=90.00° γ=90.00°
Sulfonamide benzoic acid; 2pyridone form II
C7H7NO4S,C5H5NO
Chem.Commun. (2015) 51, 15578
a=5.3090(3)Å b=10.5807(8)Å c=12.1499(10)Å
α=76.377(7)° β=89.187(6)° γ=77.195(6)°
Sulfonamide benzoic acid; isonicotinamide; 2pyridone
C7H7NO4S,C6H6N2O,C5H5NO
Chem.Commun. (2015) 51, 15578
a=20.4140(14)Å b=6.5885(4)Å c=14.7470(9)Å
α=90.00° β=101.671(6)° γ=90.00°
Sulfonamide benzoic acid; nicotinamide
C7H7NO4S,2(C6H6N2O)
Chem.Commun. (2015) 51, 15578
a=5.0179(5)Å b=11.3168(17)Å c=18.156(2)Å
α=95.966(12)° β=90.050(9)° γ=95.469(10)°
Sulfonamide benzoic acid; 3methoxy 2pyridone
C7H7NO4S,2(C6H7NO2)
Chem.Commun. (2015) 51, 15578
a=6.95437(16)Å b=12.7192(3)Å c=23.9115(5)Å
α=90.00° β=92.737(2)° γ=90.00°
Sulfonamide benzoic acid; nicotinamide; 3methoxy 2pyridone
2(C7H7NO4S),C6H6N2O,2(C6H7NO2)
Chem.Commun. (2015) 51, 15578
a=13.2514(3)Å b=7.05170(19)Å c=38.1412(9)Å
α=90.00° β=91.962(2)° γ=90.00°
Sulfonamide benzoic acid; picolinamide
C7H7NO4S,C6H6N2O
Chem.Commun. (2015) 51, 15578
a=10.2113(10)Å b=8.0850(6)Å c=17.663(2)Å
α=90.00° β=92.033(9)° γ=90.00°
Sulfonamide benzoic acid; picolinamide; 6methyl 2pyridone
C7H7NO4S,C6H6N2O,C6H7NO
Chem.Commun. (2015) 51, 15578
a=11.5333(3)Å b=7.91065(17)Å c=22.4905(7)Å
α=90.00° β=100.021(3)° γ=90.00°
Sulfonamide benzoic acid; valerolactam
C7H7NO4S,C5H9NO
Chem.Commun. (2015) 51, 15578
a=8.2121(5)Å b=9.3439(6)Å c=10.6539(8)Å
α=112.237(7)° β=106.403(6)° γ=95.743(5)°
C21H18ClNO6
C21H18ClNO6
CrystEngComm (2013) 15, 1 34
a=11.858(3)Å b=4.8452(9)Å c=16.785(3)Å
α=90.00° β=102.47(2)° γ=90.00°
From D:/data/P.Sapui/gsas_26052012/ps1.cif
C21H18ClNO6
CrystEngComm (2013) 15, 1 34
a=22.5733(13)Å b=4.89448(21)Å c=18.3874(9)Å
α=90.0° β=108.5192(27)° γ=90.0°
C6F3I3,C14H8N2
C6F3I3,C14H8N2
CrystEngComm (2017)
a=6.6699(5)Å b=34.308(3)Å c=9.1378(10)Å
α=90° β=102.639(5)° γ=90°
C14H8N2,C6F3I3
C14H8N2,C6F3I3
CrystEngComm (2017)
a=10.309(2)Å b=8.9709(18)Å c=22.251(5)Å
α=90° β=97.88(3)° γ=90°
Etoricoxib-adipic acid cocrystal
C18H15ClN2O2S,0.5(C6H10O4)
CrystEngComm (2016) 18, 16 2825
a=16.6417(18)Å b=5.4913(6)Å c=23.838(3)Å
α=90° β=98.603(2)° γ=90°
Etoricoxib-caprolactam dihydrate
2(C18H15ClN2O2S),C6H11NO,2(H2O)
CrystEngComm (2016) 18, 16 2825
a=12.552(3)Å b=12.574(3)Å c=14.989(3)Å
α=96.690(3)° β=114.553(2)° γ=90.099(3)°
Etoricoxib-gluraric acid cocrystal
C23H23ClN2O6S
CrystEngComm (2016) 18, 16 2825
a=11.8317(15)Å b=12.7266(16)Å c=15.772(2)Å
α=90° β=90.203(2)° γ=90°
Etoricoxib-suberic acid cocrystal
C18H15ClN2O2S,C8H14O4
CrystEngComm (2016) 18, 16 2825
a=9.0238(3)Å b=10.1284(5)Å c=14.8544(9)Å
α=82.766(5)° β=77.640(4)° γ=85.386(4)°
Etoricoxib-suberic acid cocrystal hydrate
2(C18H15ClN2O2S),0.5(C8H14O4),2(H2O),O
CrystEngComm (2016) 18, 16 2825
a=12.2796(15)Å b=12.4817(10)Å c=14.8713(18)Å
α=95.187(8)° β=113.754(12)° γ=91.242(8)°
Celecoxib-2-Pyrrolidinone
C17H14F3N3O2S,C4H7NO
CrystEngComm (2014) 16, 1 24
a=11.0368(5)Å b=8.6083(4)Å c=12.0762(6)Å
α=90.00° β=109.049(5)° γ=90.00°
Celecoxib-Aza-2-cyclooctanone
C17H14F3N3O2S,C7H13NO
CrystEngComm (2014) 16, 1 24
a=8.0409(5)Å b=27.2426(18)Å c=11.7927(8)Å
α=90.00° β=105.806(7)° γ=90.00°
Celecoxib-Caprolactam
C17H14F3N3O2S,C6H11NO
CrystEngComm (2014) 16, 1 24
a=11.7189(11)Å b=8.7409(6)Å c=12.0503(10)Å
α=90.00° β=103.353(10)° γ=90.00°
Celecoxib-Valerolactam-Form-I
C17H14F3N3O2S,C5H9NO
CrystEngComm (2014) 16, 1 24
a=8.7346(6)Å b=11.2689(10)Å c=12.2391(9)Å
α=81.622(7)° β=87.560(6)° γ=73.363(7)°
Celecoxib-Valerolactam-Form-II
C17H14F3N3O2S,C5H9NO
CrystEngComm (2014) 16, 1 24
a=22.591(2)Å b=8.6211(8)Å c=23.814(2)Å
α=90.00° β=102.1630(10)° γ=90.00°
Celecoxib-Valerolactam-Form-III
C17H14F3N3O2S,C6H11NO
CrystEngComm (2014) 16, 1 24
a=14.8501(18)Å b=8.4190(11)Å c=17.761(2)Å
α=90.00° β=93.901(2)° γ=90.00°
ACM-PPZ
C4H12N22,2(C21H17ClNO6)
IUCrJ (2014) 1, 2 136-150
a=7.3994(15)Å b=25.6703(19)Å c=5.8254(17)Å
α=90.162(17)° β=98.598(16)° γ=98.315(19)°
C21H18ClNO6,C7H7NO2
C21H18ClNO6,C7H7NO2
IUCrJ (2014) 1, 2 136-150
a=16.959(6)Å b=4.7993(15)Å c=17.285(5)Å
α=90.00° β=113.55(4)° γ=90.00°
Acedapsone
C16H16N2O4S
Crystal Growth & Design (2014) 14, 10 5260
a=8.2728(8)Å b=7.8636(8)Å c=23.762(2)Å
α=90.00° β=96.295(2)° γ=90.00°
Acedapsone
C16H16N2O4S
Crystal Growth & Design (2014) 14, 10 5260
a=24.519(3)Å b=8.0444(7)Å c=16.2501(15)Å
α=90.00° β=105.767(2)° γ=90.00°
C20H17Cl2N3O3
C20H17Cl2N3O3
Crystal Growth & Design (2012) 12, 4 2023
a=7.5327(13)Å b=31.313(5)Å c=9.601(3)Å
α=90.00° β=121.439(16)° γ=90.00°
C19H15Cl2N2O2
C19H15Cl2N2O2
Crystal Growth & Design (2012) 12, 4 2023
a=7.4180(6)Å b=8.2144(6)Å c=28.770(2)Å
α=90.00° β=97.099(7)° γ=90.00°
C32H32Cl4N4O4
C32H32Cl4N4O4
Crystal Growth & Design (2012) 12, 4 2023
a=7.9109(3)Å b=11.1289(4)Å c=18.1180(7)Å
α=81.943(3)° β=80.424(4)° γ=88.809(3)°
C19H17Cl2N3O2
C19H17Cl2N3O2
Crystal Growth & Design (2012) 12, 4 2023
a=14.675(4)Å b=7.1318(15)Å c=18.605(6)Å
α=90.00° β=110.73(3)° γ=90.00°
C19H19Cl2N3O3
C19H19Cl2N3O3
Crystal Growth & Design (2012) 12, 4 2023
a=16.227(4)Å b=8.4770(15)Å c=15.686(4)Å
α=90.00° β=116.18(3)° γ=90.00°
C14H10Cl2NO2
C14H10Cl2NO2
Crystal Growth & Design (2012) 12, 4 2023
a=8.5209(11)Å b=8.8775(11)Å c=9.1986(12)Å
α=104.265(2)° β=103.337(2)° γ=91.569(2)°
C18H23Cl2N3O3
C18H23Cl2N3O3
Crystal Growth & Design (2012) 12, 4 2023
a=16.137(4)Å b=8.4889(15)Å c=15.596(3)Å
α=90.00° β=114.94(3)° γ=90.00°
C18H21Cl2N3O2
C18H21Cl2N3O2
Crystal Growth & Design (2012) 12, 4 2023
a=16.3805(13)Å b=8.3717(5)Å c=14.4609(11)Å
α=90.00° β=102.347(8)° γ=90.00°
C18H21Cl2N3O2
C18H21Cl2N3O2
Crystal Growth & Design (2012) 12, 4 2023
a=7.929(3)Å b=8.168(3)Å c=28.381(15)Å
α=90.00° β=90.00° γ=90.00°
C14H10Cl2NO2
C14H10Cl2NO2
Crystal Growth & Design (2012) 12, 4 2023
a=8.566(3)Å b=8.968(3)Å c=9.378(3)Å
α=103.090(6)° β=103.194(6)° γ=92.538(6)°
C30H28Cl2N4O
C30H28Cl2N4O
Crystal Growth & Design (2012) 12, 12 6250
a=10.0842(13)Å b=12.0695(16)Å c=12.6613(16)Å
α=75.278(2)° β=66.588(2)° γ=69.051(2)°
C28H28Cl2N4O4S
C28H28Cl2N4O4S
Crystal Growth & Design (2012) 12, 12 6250
a=9.5945(12)Å b=11.0456(12)Å c=14.4628(11)Å
α=110.173(9)° β=95.859(9)° γ=94.929(9)°
C33H27Cl2N5O2
C33H27Cl2N5O2
Crystal Growth & Design (2012) 12, 12 6250
a=9.8153(9)Å b=12.1738(10)Å c=15.2122(10)Å
α=72.455(7)° β=77.844(7)° γ=66.479(8)°